Provided by Tiger Trade Technology Pte. Ltd.

Acadia

19.31
-0.1000-0.52%
Post-market: 19.310.00000.00%19:30 EDT
Volume:1.11M
Turnover:21.48M
Market Cap:2.65B
PE:57.15
High:19.59
Open:19.54
Low:19.23
Close:19.41
52wk High:23.03
52wk Low:18.61
Shares:137.33M
Float Shares:136.63M
Volume Ratio:0.70
T/O Rate:0.81%
Dividend:0.80
Dividend Rate:4.14%
EPS(TTM):0.3379
EPS(LYR):0.0950
ROE:5.71%
ROA:1.18%
PB:1.13
PE(LYR):203.20

Loading ...

Acadia Realty Trust Buys Two SoHo Storefronts on Greene Street for $60 Million

Reuters
·
Sep 14

Acadia Realty Trust Provides Investment, Balance Sheet and Leasing Update

THOMSON REUTERS
·
Sep 14

Acadia Pharmaceuticals Reaches Preliminary Derivative Lawsuit Settlement

TIPRANKS
·
Sep 12

Acadia Realty Trust to Present at BofA Securities Global Real Estate Conference

Reuters
·
Sep 09

Acadia Pharmaceuticals is Maintained at Buy by Citigroup

Dow Jones
·
Aug 25

Acadia Pharmaceuticals price target raised to $28 from $27 at Morgan Stanley

TIPRANKS
·
Aug 25

Acadia Pharmaceuticals price target raised to $40 from $39 at Citi

TIPRANKS
·
Aug 25

Analysts’ Top Real Estate Picks: Macerich (MAC), Acadia Realty (AKR)

TIPRANKS
·
Aug 24

Acadia Pharmaceuticals Gets European Approval of Rett Syndrome Drug Daybu

Dow Jones
·
Aug 24

Acadia Realty Trust Shares Rise After KeyBanc Upgrade

MT Newswires Live
·
Aug 19

Acadia Realty Trust Price Target Announced at $25.00/Share by Keybanc

Dow Jones
·
Aug 18

Acadia Realty Trust upgraded to Overweight from Sector Weight at KeyBanc

TIPRANKS
·
Aug 18

Acadia Pharmaceuticals is Maintained at Buy by UBS

Dow Jones
·
Aug 17

Acadia Realty Trust Earnings Call Signals Street Retail Strength

TIPRANKS
·
Aug 15

Acadia Pharmaceuticals to Gain From Daybue, Nuplazid Growth; RADIANT Data Adds Risk, Morgan Stanley Says

MT Newswires Live
·
Aug 10

Acadia Realty Trust Declares USD 0.20 Quarterly Dividend Per Share

Reuters
·
Aug 06

Acadia Pharmaceuticals is Maintained at Perform by Oppenheimer

Dow Jones
·
Aug 06

Acadia Pharmaceuticals: Buy Rating Reiterated as Growth Drivers Strengthen; Price Target Maintained at $36

TIPRANKS
·
Aug 05

Acadia Pharmaceuticals price target raised to $25 from $23 at Oppenheimer

TIPRANKS
·
Aug 05

Acadia Pharmaceuticals price target raised to $36 from $35 at Citizens

TIPRANKS
·
Aug 05